靶向磷脂酰肌醇蛋白聚糖 3 的肝细胞癌联合治疗策略:一篇综合性综述
Combination therapy strategies targeting glypican-3 in hepatocellular carcinoma: A comprehensive review.
肝细胞癌(HCC)仍然是全球癌症相关死亡的主要原因。
ALL SOURCES
Combination therapy strategies targeting glypican-3 in hepatocellular carcinoma: A comprehensive review.
肝细胞癌(HCC)仍然是全球癌症相关死亡的主要原因。
In Vitro Analysis of PMEPA1 Upregulation in Mesenchymal Stem Cells Induced by Prostate Cancer Cells.
前列腺跨膜蛋白雄激素诱导 1(PMEPA1)的不同亚型分别受 TGF-beta 或 AR 激活的调控,并对这些信号通路提供负反馈环路调节。
Engineering CAR-T cells for solid tumors: Overcoming the microenvironment through integrated design and clinical translation.
CAR-T 细胞疗法在血液肿瘤中已取得显著的治疗效果,而其应用于实体恶性肿瘤仍受限于约 9% 的汇总客观缓解率。
T lymphocyte-based immune response and therapy in hepatocellular carcinoma: focus on TILs and CAR-T cells.
肝细胞癌(HCC)是全球癌症相关死亡的主要原因之一。
Advanced Technologies for Cancer Immunotherapy: Focus on Gastrointestinal Cancers.
免疫治疗正成为结直肠癌、胃癌和肝癌等胃肠道肿瘤的一种替代方法。
GPC-3 in hepatocellular carcinoma; A novel biomarker and molecular target.
肝细胞癌(HCC)因诊断晚和复发率高而成为全球健康问题。
The role of glypican-3 in hepatocellular carcinoma: Insights into diagnosis and therapeutic potential.
Glypican-3(GPC-3)主要存在于胎盘和胎儿肝脏中,在成人组织中表达有限。
共 7 条
MEMBER ACCOUNT
登录成功会直接打开下一页。